Q3 Fiscal 2026
Filed Aug 13, 2026DEFSEC Technologies Inc. Announces Third Quarter Fiscal 2026 Results
Revenue increased 92% and gross margin increased to 33.1% from 28.2%, but the Company reported an Adjusted EBITDA loss of $(1,942.7) (in thousands of $, non-IFRS) and cash and short-term investments were $3,529.7 (in thousands of $) as at June 30, 2026.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Revenueother | $2,722.2 (in thousands of $, IFRS) | – | 92% |
| Gross marginother | $901.7 (in thousands of $, IFRS) | – | 126% |
| Gross margin %other | 33.1% (IFRS) | – | – |
| Operating expensesother | $3,463.1 (in thousands of $, IFRS) | – | – |
| Adjusted EBITDA lossnon-GAAP | $(1,942.7) (in thousands of $, non-IFRS) | – | – |
| Cash and short-term investmentsother | $3,529.7 (in thousands of $, as at June 30, 2026) | – | – |
| Trade and other receivablesother | $2,309.1 (in thousands of $, as at June 30, 2026) | – | – |
| Current assetsother | $6,835.2 (in thousands of $, as at June 30, 2026) | – | – |
| Total assetsother | $10,451.7 (in thousands of $, as at June 30, 2026) | – | – |
| Current liabilitiesother | $3,160.6 (in thousands of $, as at June 30, 2026) | – | – |
| Total liabilitiesother | $5,341.3 (in thousands of $, as at June 30, 2026) | – | – |
| Working capitalother | $3,674.6 (in thousands of $, as at June 30, 2026) | – | – |
What drove it
- Revenue from digitization services on Government programs was up 121% from Q3 Fiscal 2025.
- The Company commercially released DEFSEC Lightning™ 2.0 on May 6, 2026, with one Canadian police agency having subscribed ahead of full release.
- The Company commercially released ARWEN® 40mm baton ammunition on May 13, 2026; the product is in full-rate production.
- The Company completed test and evaluation of networked BLISS™ at a United States Army test center in support of a U.S. Army vehicle program.
- DEFSEC was invited to participate in a U.S. Army-hosted sensor test and evaluation scheduled for late August 2026.
Concerns
- Adjusted EBITDA loss was $(1,942.7) (in thousands of $, non-IFRS) for Q3 Fiscal 2026.
- Operating expenses were $3,463.1 (in thousands of $, IFRS), while revenue was $2,722.2 (in thousands of $, IFRS).
- Cash and short-term investments were $3,529.7 (in thousands of $) as at June 30, 2026, compared with $6,733.9 (in thousands of $) as at September 30, 2025.
- The Company cites risks related to securing contracts, statements of work and orders; financing commercial production; commercialization of BLISS™ and PARA SHOT™; and subscription growth for Lightning™ 2.0.
What to watch
- Results of the U.S. Army-hosted BLISS™ sensor test and evaluation scheduled for late August 2026.
- Whether BLISS™ testing and evaluation results in follow-on orders.
- Subscription uptake for DEFSEC Lightning™ 2.0.
- Demand for ARWEN® 40mm baton ammunition following its commercial release and full-rate production.
- Cash and short-term investments, working capital and the Company's ability to raise additional capital when required.
Balance sheet and cash flow
- Cash and short-term investments were $3,529.7 (in thousands of $) as at June 30, 2026, compared with $6,733.9 (in thousands of $) as at September 30, 2025.
- Trade and other receivables were $2,309.1 (in thousands of $) as at June 30, 2026, compared with $1,494.2 (in thousands of $) as at September 30, 2025.
- Working capital was $3,674.6 (in thousands of $) as at June 30, 2026, compared with $6,027.8 (in thousands of $) as at September 30, 2025.
Analysis
DEFSEC reported Q3 Fiscal 2026 revenue of $2,722.2 (in thousands of $, IFRS), compared with $1,417.5 (in thousands of $, IFRS) in Q3 Fiscal 2025. The release states that total revenue was up 92% and that digitization-services revenue on Government programs was up 121% from Q3 Fiscal 2025. Management characterized the quarter's defence software growth as evidence of progress toward a predictable, long-term stable revenue and margin base from military programs.
Gross margin was $901.7 (in thousands of $, IFRS), compared with $399.5 (in thousands of $, IFRS), and gross margin was 33.1%, compared with 28.2%. The release identifies a 126% gross-margin-dollar increase. Operating expenses were $3,463.1 (in thousands of $, IFRS), compared with $2,221.8 (in thousands of $, IFRS), while Adjusted EBITDA loss was $(1,942.7) (in thousands of $, non-IFRS), compared with $(1,491.5) (in thousands of $, non-IFRS).
The Company advanced several commercialization initiatives in the period. DEFSEC Lightning™ 2.0 was commercially released on May 6, 2026, with one Canadian police agency subscribed before full release. ARWEN® 40mm baton ammunition was commercially released on May 13, 2026 and is in full-rate production. Separately, BLISS™ completed testing at a United States Army test center in support of a U.S. Army vehicle program, and DEFSEC received an invitation to a further U.S. Army-hosted evaluation scheduled for late August 2026.
Liquidity measures were lower than the September 30, 2025 comparison date. Cash and short-term investments were $3,529.7 (in thousands of $), versus $6,733.9 (in thousands of $), while working capital was $3,674.6 (in thousands of $), versus $6,027.8 (in thousands of $). Trade and other receivables were $2,309.1 (in thousands of $), compared with $1,494.2 (in thousands of $). The release did not provide quantitative forward guidance, operating cash flow, free cash flow, debt, earnings per share, or capital-return figures.
Management, verbatim
The continued growth this quarter in our defence software business is further evidence of our commitment to growing a predictable, long-term stable base of revenue and margin from strategically important military programs,
Sean Homuth, President and CEO
Achieving these product commercialization milestones marks an important step in catalyzing further revenue growth and diversification in the public safety market,
Sean Homuth, President and CEO
The completion of US Army testing and this latest invitation to demonstrate BLISS™ at an additional U.S. Army-hosted event is strong validation of our technology roadmap for battlespace laser detection and intelligence,
Sean Homuth, President and CEO
Not in the filing
stated, not guessed- GAAP or IFRS operating income or operating loss
- Net income or net loss
- GAAP or IFRS earnings per share
- Non-GAAP earnings per share
- Operating cash flow
- Free cash flow
- Debt
- Capital returns, including share repurchases and dividends
- Revenue by reportable segment
- Gross-margin guidance
- Revenue guidance
- Operating-expense guidance
- Tax-rate guidance
- Prior-quarter comparisons
- Quantitative forward guidance
- Prior outlook for comparison
AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.